Background Image
Table of Contents Table of Contents
Previous Page  421 / 658 Next Page
Information
Show Menu
Previous Page 421 / 658 Next Page
Page Background

5

Thermo Scientific Poster Note

PN-60477-ASMS-EN-0614S

For forensic use only.

All trademarks are the property of Thermo

This information is not intended to encoura

intellectual property rights of others.

mpounds

TABLE 3. Transitions and MS parameters for all compounds

.5 4.0

4.14

0.5

1.0

1.5

2.0

2.5

3.0

Time (min)

0

20

40

60

80

100

0

20

40

60

80

100

0

20

40

60

80

100

Relative Abundance

0

20

40

60

80

100

1.65

1.47

1.79

1.65

1.46

1.79

2.38

odone

Hydromorphone-

3

b

-glucuronide

(1.65)

Codeine-6

b

-

glucuronide

Morphine-3

b

-

glucuronide (1.47)

Morphine-6

b

-

glucuronide (1.79)

Oxymorphon-3

b

-

glucuronide

1.46

Precision

(%RSD)

Intra-Assay

Inter-Assay

<14.3

<5.7

<14.1

<8.2

<8.8

<4.8

<10.3

<3.5

<14.1

<5.8

<9.6

<4.1

<11.1

<5.3

<13.6

<5.7

<13.5

<9.2

<14.1

<5.8

<11.6

<10.4

<7.4

<5.0

<9.7

<4.4

<8.5

<4.1

<14.4

<4.4

<7.9

<5.7

<14.9

<4.1

<10.8

<3.7

<6.1

<6.9

Analyte

Precursor

Ion (Q1)

Product

Ions (Q3)

CE

(V)

S-lens

(V)

Normorphine

272.0

165.0

59

95

209.0

40

95

Morphine-3

b

-glucuronide

462.1

286.1

52

148

185.2

58

139

Oxymorphone-3

b

-glucuronide

478.1

284.1

47

147

302.1

42

147

Hydromorphone-3

b

-glucuronide

462.1

185.2

58

139

286.1

52

148

Morphine-6

b

-glucuronide

462.1

286.1

52

148

185.2

58

139

Codeine-6

b

-glucuronide

476.2

300.2

31

114

215.2

39

114

6-Acetylmorphine

328.1

165.0

58

112

211.0

39

112

6-Acetylcodeine

342.1

225.1

27

109

165.1

47

109

Dihydromorphine

288.1

185.1

48

95

165.0

59

95

Morphine

286.1

165.1

64

90

185.0

44

119

Oxymorphone

302.0

227.0

40

116

199.1

55

116

Hydromorphone

286.1

185.0

44

119

165.1

64

90

Codeine

300.0

171.0

40

119

199.1

43

119

Dihydrocodeine

302.0

201.1

42

93

199.0

52

93

Norcodeine

286.1

165.1

64

90

181.6

49

90

Oxycodone

316.0

241.1

41

119

256.0

40

119

Noroxycodone

302.1

227.0

41

116

187.0

40

116

Norhydrocodone

286.1

199.0

39

119

241.1

35

119

Hydrocodone

300.0

171.1

40

119

181.1

51

94

Noroxycodone-d

3

305.1

190.1

25

116

Norhydrocodone-d

3

289.1

152.1

62

116

6-Acetylmorphine-d

6

334.1

165.1

38

116

Morphine-6

b

-glucuronide-d

3

465.1

289.1

32

140

Morphine-d

3

289.1

152.1

61

116

Dihydrocodeine-d

6

308.1

202.1

34

116

Codeine-d

6

306.1

165.1

43

116

Hydromorphone-d

6

292.1

185.1

32

116

Morphine-3

b

-glucuronide-d

3

465.1

289.1

31

140

Oxycodone-d

6

322.1

218.1

43

116

FIGURE 4. Molecular structu

hydromorphone (H)

Hydromorphone-3

b

D-glu

Conclusion

This quantitative method

and their metabolites wit

Verification of a forensic

Prelude SPLC system a

can analyze these proble

This forensic method is

less costly then those th

eliminated from the work

The Prelude SPLC syste

necessary chromatograp

of all compounds.

ms for all 19 compounds

Morphine-6

b

-

Glucuronide

Area Ratio

Concentration (ng/mL)

Area Ratio

Oxymorphone-3

b

-

Glucuronide

Concentration (ng/mL)

FIGURE 3. Representative calibration curves for the intact glucuronides

Figure 4 displays molecular st

hydromorphone. The starting

molecule, which exists before

analyzes this structure as a w

Table 4 shows the results of a

nonhydrolyzed samples. Anal

results as does analyzing the

TABLE 4. Comparison of hydr

concentration from hydrolyze

Prepared concentration (ng/mL

Measured concentration prior t

Measured concentration after h

Expected % converted to pare

weight (285/461=62)

Actual % measured based on r

% Difference